8-K: Cencora Repurchases $250 Million of Shares from Walgreens Boots Alliance

Cencora, Inc. has repurchased approximately $250 million of its common stock from Walgreens Boots Alliance Holdings LLC as part of a larger share sale by the latter.

Summary

• Cencora, Inc. entered into a share repurchase agreement with Walgreens Boots Alliance Holdings LLC on August 1, 2024.
• Cencora repurchased 1,039,242 shares of its common stock directly from Walgreens Boots Alliance Holdings LLC.
• The repurchase price per share matched the price at which Walgreens Boots Alliance Holdings LLC sold shares in a separate Rule 144 sale.
• The total cost of the repurchase was approximately $250 million.
• The repurchase was completed on August 5, 2024, and the shares will be held in treasury.
• Walgreens Boots Alliance Holdings LLC sold 3,398,929 shares of Cencora stock under Rule 144 on August 1, 2024.
• Following the sale and repurchase, Walgreens Boots Alliance Holdings LLC owns 19,980,000 shares, representing about 10.2% of Cencora's outstanding shares.

Sentiment

Score: 7

Explanation: The sentiment is positive as the company is using its cash to repurchase shares, which is generally seen as a positive sign. The transaction is part of a planned reduction in ownership by a major shareholder, which is not necessarily negative but does not indicate a strong positive outlook.

Positives

• The share repurchase reduces the number of outstanding shares, potentially increasing earnings per share.
• The repurchase demonstrates Cencora's confidence in its financial position and future prospects.
• The company used cash on its balance sheet to complete the repurchase.

Risks

• The share repurchase was contingent on the completion of the Rule 144 sale by Walgreens Boots Alliance Holdings LLC.
• The agreement could have been terminated if the conditions were not met.

Management Comments

• The repurchase was made under the company's share repurchase program.

Industry Context

Share repurchases are a common method for companies to return value to shareholders and can signal management's confidence in the company's future performance. This transaction is a specific agreement with a major shareholder, Walgreens Boots Alliance, which is reducing its stake in Cencora.

Comparison to Industry Standards

• Share repurchases are a common practice among large, established companies like Cencora, especially when they have strong cash flow.
• Other companies in the pharmaceutical distribution industry, such as McKesson and Cardinal Health, also engage in share repurchase programs.
• The size of this repurchase, $250 million, is significant but not unusual for a company of Cencora's size.
• The repurchase price being tied to the Rule 144 sale price is a common practice in these types of transactions to ensure fair market value.

Related Party Transactions

• The share repurchase is a related party transaction between Cencora and Walgreens Boots Alliance Holdings LLC.

Stakeholder Impact

• Shareholders may view the repurchase positively as it can increase earnings per share.
• The reduction in Walgreens Boots Alliance Holdings LLC's stake could lead to changes in the shareholder base.

Key Dates

Keywords

share repurchase, stock buyback, Walgreens Boots Alliance, Cencora, Rule 144, treasury stock, share sale